Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData

expresspharmaAugust 04, 2020

Tag: GlobalData , NPPA , Remdesivir , favipiravir

PharmaSources Customer Service